Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study

Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study

Endothelial dysfunction (ED) is frequently found in patients with heart failure (HF). Among several pharmacological agents reported to improve endothelial function, levosimendan seems to be a promising one, even though, to date, only two previously published studies have evaluated its effects on ED...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Alessandro Maloberti, Jinwei Sun, Jessica Zannoni, Lucia Occhi, Ilaria Bassi, Saverio Fabbri, Valentina Colombo, Elena Gualini, Michela Algeri, Marisa Varrenti, Gabriella Masciocco, Enrico Perna, Fabrizio Oliva, Manlio Cipriani, Maria Frigerio, Cristina Giannattasio
التنسيق: مقال
اللغة:English
منشور في: MDPI AG 2022-08-01
سلاسل:Life
الموضوعات:
endothelial dysfunction
flow-mediated vasodilation
levosimendan
heart failure
الوصول للمادة أونلاين:https://www.mdpi.com/2075-1729/12/9/1322

الانترنت

https://www.mdpi.com/2075-1729/12/9/1322

مواد مشابهة